A Study to Evaluate the Effect of Multiple Doses of Enzalutamide on the Pharmacokinetics of Substrates of P-glycoprotein (Digoxin) and Breast Cancer Resistant Protein (Rosuvastatin) in Male Subjects With Prostate Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Prostate Cancer
Interventions: DRUG: enzalutamide|DRUG: enzalutamide Placebo|DRUG: digoxin|DRUG: rosuvastatin
Sponsor: Astellas Pharma Global Development, Inc.
Collaborators: Pfizer